-
Combination therapy ‘favourable’ in long-term acne treatment
europeanpharmaceuticalreview
April 30, 2019
According to Rutgers researchers, physicians are scaling back on prescribing antibiotics for long-term acne treatment in favour of a combination of therapies.
-
BiomX raises funds to advance drug candidates for acne and IBD
pharmaceutical-technology
February 22, 2019
Israeli drug discovery firm BiomX has raised funds in a series B round to advance its lead acne and inflammatory bowel disease (IBD) drug programmes to the clinic.....
-
Dermatologists' Rx for Antibiotics Dropped From 2008 to 2016
drugs
January 17, 2019
Dermatologists' use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing, according to a study published online Jan. 16 in JAMA Dermatology.....
-
Glenmark gets US FDA nod for generic acne treatment gel
expressbpd
November 20, 2018
Citing market data, the company said for the 12-month period ended September 2018, Finacea Gel (15 per cent ) achieved annual sales of approximately $ 64.1 million.
-
Ortho Dermatologics Announces U.S. FDA Filing Acceptance for IDP-121 Acne Treatment in Lotion Form
biospace
January 15, 2018
Valeant Division Ortho Dermatologics announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application IDP-121 (tretinoin 0.05%) Lotion (ALTRENO ™ 1)
-
BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans
americanpharmaceuticacreview
November 09, 2017
Consistent with oral minocycline products, BPX-01 is intended for the targeted treatment of non-nodular inflammatory acne vulgaris.
-
Allergan and Paratek Announce Positive Results from Two Phase 3 Trials of Sarecycline for the Treatm
americanpharmaceuticalreview
March 28, 2017
Allergan and Paratek Pharmaceuticals, Inc. announced that two Phase 3 trials of sarecycline for the treatment of moderate to severe acne met their 12 week primary efficacy endpoints.